Cargando…
CX(3)C chemokine receptor 1 deficiency modulates microglia morphology but does not affect lesion size and short-term deficits after experimental stroke
BACKGROUND: The fractalkine/CX(3)C chemokine receptor 1 (CX(3)CR1) pathway has been identified to play an essential role in the chemotaxis of microglia, leukocyte trafficking and microglia/macrophage recruitment. It has also been shown to be important in the regulation of the inflammatory response i...
Autores principales: | van der Maten, Gerlinde, Henck, Vivien, Wieloch, Tadeusz, Ruscher, Karsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5219711/ https://www.ncbi.nlm.nih.gov/pubmed/28061814 http://dx.doi.org/10.1186/s12868-016-0325-0 |
Ejemplares similares
-
Treatment with AMD3100 attenuates the microglial response and improves outcome after experimental stroke
por: Walter, Helene L, et al.
Publicado: (2015) -
Effect of Anti-inflammatory Treatment with AMD3100 and CX(3)CR1 Deficiency on GABA(A) Receptor Subunit and Expression of Glutamate Decarboxylase Isoforms After Stroke
por: Michalettos, Georgios, et al.
Publicado: (2021) -
Plasticity-Enhancing Effects of Levodopa Treatment after Stroke
por: Talhada, Daniela, et al.
Publicado: (2021) -
Enriched Housing Enhances Recovery of Limb Placement Ability and Reduces Aggrecan-Containing Perineuronal Nets in the Rat Somatosensory Cortex after Experimental Stroke
por: Madinier, Alexandre, et al.
Publicado: (2014) -
Neuroprotective dobutamine treatment upregulates superoxide dismutase 3, anti-oxidant and survival genes and attenuates genes mediating inflammation
por: Markus, Tina, et al.
Publicado: (2018)